| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2010 ( Subtotal = $300,000 ) |
| | 2010 | 2010 | ACHILLION PHARMACEUTICALS INC | 300 GEORGE STREET | NEW HAVEN | CT | 06511-6624 | SOUTH CENTRAL CT | USA | R43AI085797 | NOVEL ANTIBACTERIAL AGENTS THAT TARGET DNA REPLICATION IN MYCOBACTERIUM TUBERCULO | 000 | 1 | NIH | 3/15/2010 | $300,000 |
|
| Issue Date FY: 2006 ( Subtotal = $301,407 ) |
| | 2006 | 2006 | ACHILLION PHARMACEUTICALS INC | 300 GEORGE STREET | NEW HAVEN | CT | 06511 | SOUTH CENTRAL CT | USA | R43AI064090 | CAPSID ASSEMBLY INHIBITORS FOR THE TREATMENT OF AIDS | 000 | 2 | NIH | 2/24/2006 | $301,407 |
|
| Issue Date FY: 2005 ( Subtotal = $296,258 ) |
| | 2005 | 2005 | ACHILLION PHARMACEUTICALS INC | 300 GEORGE STREET | NEW HAVEN | CT | 06511 | SOUTH CENTRAL CT | USA | R43AI064090 | CAPSID ASSEMBLY INHIBITORS FOR THE TREATMENT OF AIDS | 000 | 1 | NIH | 3/2/2005 | $296,258 |
|
|
